| Record ID | marc_university_of_toronto/uoft.marc:2002702808:1697 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:2002702808:1697?format=raw |
LEADER: 01697cam 2200349 a 4500
005 19990409112301.4
008 981007s1998 gw a b 100 0 eng d
020 $a3886036332
072 7 $aRM$2lcco
090 08 $aRM 301.27 .E865 1998$bGERSTM$c1
090 $oOn order for Central System
110 2 $aEuropean Association for Clinical Pharmacology and Therapeutics.$bCongress$n(2nd :$d1997 :$cBerlin, Germany).
245 10 $aWhat should a clinical pharmacologist know to start a clinical trial (phase I and II)? :$bproceedings of symposium 10, 2nd Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17-20, 1997 /$cJ. Kuhlmann, A. Mrozikiewicz (eds.).
260 $aMünchen ;$aNew York :$bW. Zuckschwerdt Verlag,$cc1998.
300 $aviii, 67 p. :$bill. ;$c24 cm.
490 1 $aKlinische Pharmakologie ;$v16 =$aClinical pharmacology,$x0937-0978
504 $aIncludes bibliographical references.
650 2 $aClinical Trials, Phase I$vcongresses
650 2 $aClinical Trials, Phase II$vcongresses
650 0 $aClinical trials$xCongresses.
650 2 $aDrug Evaluation$vcongresses
650 0 $aDrug evaluation$xCongresses.
650 0 $aDrugs$xTesting$xCongresses.
650 2 $aPharmacology, Clinical$vcongresses
700 1 $aKuhlmann, J.$q(Jochen)
700 1 $aMrozikiewicz, A.
830 0 $aKlinische Pharmakologie ;$v16.
948 $a11/20/1998$b08/06/2001
039 $fsom/som(som)
039 $fpvv
949 $aRM301.27 .E865 1998$wLC$c1$i31761047346911$d27/9/2007$e18/9/2007$lSTACKS$mGERSTEIN$n15$q4$rY$sY$tBOOK$u13/4/1999
949 $aBAB-5048$wLC$c1$i2273176-2001$lCLOSED_ORD$mCOLL_DEV$rY$sY$tUNKNOWN$u16/10/2002